RGD Reference Report - Applicability of a "speed" congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Applicability of a "speed" congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2.

Authors: Jeffs, B  Negrin, CD  Graham, D  Clark, JS  Anderson, NH  Gauguier, D  Dominiczak, AF 
Citation: Jeffs B, etal., Hypertension 2000 Jan;35(1 Pt 2):179-87.
RGD ID: 68910
Pubmed: PMID:10642295   (View Abstract at PubMed)

The identification of any quantitative trait locus (QTL) via a genome scan is only the first step toward the ultimate goal of gene identification. The next step is the production of congenic strains by which the existence of a QTL may be verified and the implicated chromosomal region be reduced to a size applicable to positional cloning of the causal gene. We used a speed congenic breeding protocol previously verified in mice for 2 blood pressure QTLs on rat chromosome 2. Four congenic strains were produced through introgression of various segments of chromosome 2 from Wistar-Kyoto rats from Glasgow colonies [WKY((Gla)) rats] into the recipient stroke-prone spontaneously hypertensive rats from Glasgow colonies [SHRSP((Gla))], and vice versa. The number of backcross generations required for each strain to achieve complete homozygosity at 83 background genetic markers in a "best" male varied between 3 and 4. Transfer of the region of rat chromosome 2 containing both QTLs from WKY((Gla)) into an SHRSP((Gla)) genetic background lowered both baseline and salt-loaded systolic blood pressure by approximately 20 and approximately 40 mm Hg in male congenic rats compared with the SHRSP parental strain (F=53.4, P<0.005; F=28.0, P< 0.0005, respectively). In contrast, control animals for stowaway heterozygosity presented no deviation from the blood pressure values recorded for the SHRSP((Gla)), indicating that if such heterozygosity exists, its effect on blood pressure is negligible. A reciprocal strategy in which 1 or both QTLs on rat chromosome 2 were transferred from SHRSP((Gla)) into a WKY((Gla)) genetic background resulted in statistically significant but smaller blood pressure increases for 1 of these QTLs. These results confirm the existence of blood pressure QTLs on rat chromosome 2 and demonstrate the applicability of a speed congenic strategy in the rat and emphasize the important role of the genetic background.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
Bp132Rathypertension  IDA  RGD 
Bp163Rathypertension  IDA  RGD 
Cm14Rathypertension  IAGP  RGD 
SHRSP.WKY-(D2Rat13-D2Mit5)/GcrcRathypertension sexual_dimorphism IAGP  RGD 
SHRSP.WKY-(D2Rat13-D2Mit5)/GcrcRathypertension susceptibilityIAGP compared to control strain WKY/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Rat157)/GcrcRathypertension sexual_dimorphism IAGP compared to WKY/GcrcRGD 
SHRSP/GcrcRathypertension MODEL: spontaneousIAGP compared to control strain WKY/GcrcRGD 
WKY.SHRSP-(D2Mit5-D2Mgh12)/GcrcRathypertension susceptibilityIAGP compared to control strain WKY/GcrcRGD 
WKY/GcrcRathypertension MODEL: controlIAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 

Phenotype Annotations    Click to see Annotation Detail View

Mammalian Phenotype

Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
WKY/GcrcRatdecreased mean systemic arterial blood pressure  IAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Rat157)/GcrcRatdecreased susceptibility to hypertension susceptibilityIAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
WKY.SHRSP-(Fst-Pklr)/GcrcRatdecreased susceptibility to hypertension susceptibilityIAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
WKY/GcrcRatdecreased susceptibility to hypertension  IAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
WKY.SHRSP-(Fst-Pklr)/GcrcRatdecreased systemic arterial blood pressure  IAGP  RGD 
WKY/GcrcRatdecreased systemic arterial diastolic blood pressure  IAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Rat157)/GcrcRatdecreased systemic arterial systolic blood pressure susceptibilityIAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
WKY/GcrcRatdecreased systemic arterial systolic blood pressure  IAGP compared to spontaneously hypertensive strain SHRSP/GcrcRGD 
Bp163Ratincreased heart weight  IAGP  RGD 
SHRSP.WKY-(D2Rat13-D2Rat157)/GcrcRatincreased mean systemic arterial blood pressure sexual_dimorphism IAGP compared to WKY/GcrcRGD 
SHRSP/GcrcRatincreased mean systemic arterial blood pressure disease_progressionIAGP compared to control strain WKY/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Mit5)/GcrcRatincreased susceptibility to hypertension susceptibilityIAGP compared to control strain WKY/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Mit5)/GcrcRatincreased susceptibility to hypertension sexual_dimorphism IAGP  RGD 
SHRSP/GcrcRatincreased susceptibility to hypertension disease_progressionIAGP compared to control strain WKY/GcrcRGD 
WKY.SHRSP-(D2Mit5-D2Mgh12)/GcrcRatincreased susceptibility to hypertension susceptibilityIAGP compared to control strain WKY/GcrcRGD 
Bp132Ratincreased systemic arterial blood pressure  IAGP  RGD 
Bp163Ratincreased systemic arterial blood pressure  IAGP  RGD 
WKY.SHRSP-(D2Mit5-D2Mgh12)/GcrcRatincreased systemic arterial blood pressure  IAGP  RGD 
SHRSP.WKY-(D2Rat13-D2Rat157)/GcrcRatincreased systemic arterial diastolic blood pressure sexual_dimorphism IAGP compared to WKY/GcrcRGD 
SHRSP/GcrcRatincreased systemic arterial diastolic blood pressure disease_progressionIAGP compared to control strain WKY/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Rat157)/GcrcRatincreased systemic arterial systolic blood pressure sexual_dimorphism IAGP compared to WKY/GcrcRGD 
SHRSP/GcrcRatincreased systemic arterial systolic blood pressure disease_progressionIAGP compared to control strain WKY/GcrcRGD 
WKY.SHRSP-(D2Mit5-D2Mgh12)/GcrcRatincreased systemic arterial systolic blood pressure susceptibilityIAGP compared to control strain WKY/GcrcRGD 
WKY.SHRSP-(D2Mit5-D2Mgh12)/GcrcRatsalt-resistant hypertension  IAGPcontrolled sodium content drinking watercompared to spontaneously hypertensive strain SHRSP/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Mit5)/GcrcRatsalt-sensitive hypertension susceptibilityIAGPcontrolled sodium content drinking watercompared to control strain WKY/GcrcRGD 
SHRSP.WKY-(D2Rat13-D2Mit5)/GcrcRatsalt-sensitive hypertension sexual_dimorphism IAGP  RGD 
SHRSP/GcrcRatsalt-sensitive hypertension susceptibilityIAGPcontrolled sodium content drinking watercompared to control strain WKY/Gcrc and sexual dimorphismRGD 

Objects Annotated

QTLs
Bp132  (Blood pressure QTL 132)
Bp163  (Blood pressure QTL 163)
Cm14  (Cardiac mass QTL 14)

Strains
SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc  (NA)
SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc  (NA)
SHRSP/Gcrc  (Spontaneously hypertensive rat, stroke prone)
WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc  (NA)
WKY.SHRSP-(Fst-Pklr)/Gcrc  (NA)
WKY/Gcrc  (Wistar-Kyoto)

Objects referenced in this article
QTL Bp13 Blood pressure QTL 13 Rattus norvegicus
QTL Bp14 Blood pressure QTL 14 Rattus norvegicus
QTL Bp6 Blood pressure QTL 6 Rattus norvegicus

Additional Information